Mycobacterium bovis

From WikiMD's WELLNESSPEDIA

(Redirected from Bovine tuberculosis)

Mycobacterium bovis (M. bovis) is a slow-growing aerobic bacterium and the causative agent of tuberculosis in cattle (known as bovine TB). It is related to Mycobacterium tuberculosis, the bacterium which causes tuberculosis in humans. M. bovis can jump the species barrier, usually from infected mammals to humans, leading to zoonotic TB.

Characteristics[edit]

M. bovis is a small, aerobic, nonmotile bacillus. It is characterized by its slow growth rate, taking up to six weeks to form visible colonies. The bacterium is a facultative intracellular parasite, usually of macrophages, with a slow replication time, between 15–20 hours.

Pathogenesis[edit]

M. bovis causes TB and can affect all mammals, including humans. The disease is spread in the air when people who are sick with pulmonary TB expel bacteria, such as through coughing. Infection is established in the lungs and the regional lymph nodes.

Diagnosis[edit]

Diagnosis of M. bovis involves isolating the bacterium from a clinical specimen. The use of PCR technology has also been developed to detect and identify mycobacteria.

Treatment[edit]

Treatment of M. bovis infection in humans is difficult and requires long courses of multiple antibiotics. Active disease due to M. bovis is resistant to pyrazinamide, one of the first-line drugs for TB.

Prevention[edit]

Prevention of M. bovis is achieved by a combination of a test and slaughter policy in cattle, and by pasteurization of milk.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.